Literature DB >> 10616018

Patterns of disease activity in systemic lupus erythematosus.

S G Barr1, A Zonana-Nacach, L S Magder, M Petri.   

Abstract

OBJECTIVE: To describe patterns of systemic lupus (SLE) disease activity over time.
METHODS: Disease activity was measured in a prospective cohort of 204 consecutive SLE patients followed up quarterly for 2.0-7.5 years (911 person-years of followup). Physician's global assessment (PGA) and modified SLE Disease Activity Index (M-SLEDAI; omitting serology) scores were plotted against time for each patient. Definitions for disease activity patterns were developed by consensus using these plots, and the proportion of total follow-up time represented by each pattern was calculated.
RESULTS: Three patterns of SLE activity were apparent: relapsing-remitting (RR), chronic active (CA), and long quiescent (LQ). The CA pattern was the most frequent for both the PGA and M-SLEDAI, representing 58% and 40% of total person-years, respectively. The least common pattern was LQ (PGA 16%, M-SLEDAI 25%), while the RR pattern was intermediate in frequency (PGA 26%, M-SLEDAI 35%). Average disease activity during RR periods tended to be mild, while that during CA periods was more likely to be moderately severe. The most common discrepancy between instruments was that the PGA depicted CA when the M-SLEDAI showed an RR pattern. The M-SLEDAI did not appear to capture mild degrees of activity.
CONCLUSION: SLE activity was readily classified into 1 of 3 patterns: RR, CA, or LQ. The CA pattern was most common, suggesting that significant morbidity may arise from persistent disease activity. These findings may have important implications regarding the choice of outcome measures in SLE clinical trials, since comparison of flare rates may not account for chronic disease activity.

Entities:  

Mesh:

Year:  1999        PMID: 10616018     DOI: 10.1002/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO;2-6

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  25 in total

1.  Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

Authors:  Di Feng; Rivka C Stone; Maija-Leena Eloranta; Niquiche Sangster-Guity; Gunnel Nordmark; Snaevar Sigurdsson; Chuan Wang; Gunnar Alm; Ann-Christine Syvänen; Lars Rönnblom; Betsy J Barnes
Journal:  Arthritis Rheum       Date:  2010-02

2.  Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus.

Authors:  Loes van den Berg; Hans Nossent; Ole Rekvig
Journal:  Clin Rheumatol       Date:  2005-11-23       Impact factor: 2.980

3.  Predictors of predominant Lupus Low Disease Activity State (LLDAS-50).

Authors:  H Babaoglu; J Li; D Goldman; L S Magder; M Petri
Journal:  Lupus       Date:  2019-11-06       Impact factor: 2.911

4.  Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps.

Authors:  Nishant Dwivedi; Jagriti Upadhyay; Indira Neeli; Salar Khan; Debendra Pattanaik; Linda Myers; Kyriakos A Kirou; Bernhard Hellmich; Bryan Knuckley; Paul R Thompson; Mary K Crow; Ted R Mikuls; Elena Csernok; Marko Radic
Journal:  Arthritis Rheum       Date:  2011-10-27

5.  Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX.

Authors:  J Zhang; L A González; J M Roseman; L M Vilá; J D Reveille; G S Alárcon
Journal:  Lupus       Date:  2010-01-29       Impact factor: 2.911

6.  Causes and predictors of death in Brazilian lupus patients.

Authors:  Rosa Weiss Telles; Cristina Costa Duarte Lanna; Fabiana Lemos Souza; Luciana Andrade Rodrigues; Rodrigo Citton Padilha Reis; Antonio Luiz Ribeiro
Journal:  Rheumatol Int       Date:  2012-03-30       Impact factor: 2.631

7.  Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies.

Authors:  A Ghirardello; A Doria; S Zampieri; R Gerli; E Rapizzi; P F Gambari
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

8.  Predictors of self-reported health-related quality of life in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Vibeke Strand; Hong Fang; Jawali Jaranilla; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2013-05-16       Impact factor: 7.580

9.  Rheumatoid factor B cell memory leads to rapid, switched antibody-forming cell responses.

Authors:  Rebecca A Sweet; Jaime L Cullen; Mark J Shlomchik
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

Review 10.  Disease activity assessment in SLE: do we have the right instruments?

Authors:  Michelle Petri
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.